PubRank

Keiichi Enjyoji

Author PubWeight™ 40.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003 3.71
2 CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002 3.18
3 Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005 1.86
4 From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 2009 1.75
5 CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010 1.69
6 Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest 2003 1.34
7 Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am J Pathol 2007 1.32
8 Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 2004 1.31
9 Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 2008 1.27
10 Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis 2006 1.24
11 The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Front Biosci 2008 1.24
12 Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology 2008 1.15
13 NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur J Immunol 2010 1.09
14 Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology 2010 1.09
15 The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia 2008 1.08
16 Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal 2011 1.06
17 P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One 2013 1.03
18 Role of the ectonucleotidase NTPDase2 in taste bud function. Proc Natl Acad Sci U S A 2013 1.03
19 The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 2007 1.02
20 Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology 2007 1.00
21 Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med 2010 0.92
22 Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. Am J Physiol Renal Physiol 2008 0.90
23 Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes 2008 0.88
24 Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc Res 2002 0.86
25 Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia. Purinergic Signal 2011 0.84
26 Variable impact of CD39 in experimental murine colitis. Dig Dis Sci 2010 0.82
27 Defective renal water handling in transgenic mice over-expressing human CD39/NTPDase1. Am J Physiol Renal Physiol 2012 0.80
28 HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries. Int J Cardiol 2008 0.78
29 NTPDase2 and purinergic signaling control progenitor cell proliferation in neurogenic niches of the adult mouse brain. Stem Cells 2015 0.78
30 Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice. Purinergic Signal 2009 0.78
31 Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans. J Clin Endocrinol Metab 2015 0.77
32 Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation. Transpl Int 2012 0.77
33 Preservation of cochlear function in Cd39 deficient mice. Hear Res 2009 0.77
34 Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma. Purinergic Signal 2014 0.76